Total Funding
3
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
63699
Visus Therapeutics is a clinical-stage company developing innovative medicines.
Acquired by 
Tenpoint Therapeutics
Ben Bergo: Co-Founder, Executive Director, Chief Executive Officer & Board MemberPast Role: Planet Innovation, Executive Director- Julia Williams: VP of Clinical ,Medical Affairs & Expansion of Irvine Co-HeadquartersPast Role: Aerie Pharmaceuticals, VP of Medical Affairs
About the Company
Visus Therapeutics is a clinical-stage company developing innovative medicines to improve the vision for people around the world.
